methylene blue has been researched along with Progeria in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharti, P; Cao, K; Mao, X; Thaivalappil, A | 1 |
| Cao, K; Choi, JY; Ko, E; LaDana, C; Sesaki, H; Tariq, Z; Wang, K; Wu, D; Xiong, ZM; Zhang, H | 1 |
2 other study(ies) available for methylene blue and Progeria
| Article | Year |
|---|---|
Peroxisomal abnormalities and catalase deficiency in Hutchinson-Gilford Progeria Syndrome.
Topics: Acatalasia; Cell Line; Cellular Senescence; Enzyme Inhibitors; Everolimus; Fibroblasts; Humans; Lamin Type A; Methylene Blue; Mutation; Peroxisomes; Phenotype; Progeria; Reactive Oxygen Species | 2020 |
Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria.
Topics: Aging, Premature; Cell Growth Processes; Cell Line; Cell Nucleus; Fibroblasts; Gene Expression Regulation; Humans; Methylene Blue; Mitochondria; Progeria; Up-Regulation | 2016 |